Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies

COVID-19 antibody testing has been developed to investigate humoral immune response in SARS-CoV-2 infection. To assess the serological dynamics and neutralizing potency following SARS-CoV-2 infection, we investigated the neutralizing (NT) antibody, anti-spike, and anti-nucleocapsid antibodies respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Maika, Ai, Tomohiko, Sinozuka, Konomi, Baba, Yuna, Igawa, Gene, Nojiri, Shuko, Yamamoto, Takamasa, Yuri, Maiko, Takei, Satomi, Saito, Kaori, Horiuchi, Yuki, Kanno, Takayuki, Tobiume, Minoru, Khasawneh, Abdullah, Paran, Faith Jessica, Hiki, Makoto, Wakita, Mitsuru, Miida, Takashi, Suzuki, Tadaki, Okuzawa, Atsushi, Takahashi, Kazuhisa, Naito, Toshio, Tabe, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436163/
https://www.ncbi.nlm.nih.gov/pubmed/36050347
http://dx.doi.org/10.1038/s41598-022-19073-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436163/
https://www.ncbi.nlm.nih.gov/pubmed/36050347
http://dx.doi.org/10.1038/s41598-022-19073-z

Ejemplares similares